Incorporated in 1887 in New Brunswick, New Jersey, Johnson & Johnson is a holding pharmaceutical and consumer-healthcare company with more than 250 operating companies in about 60 countries and a product-reach in over 175 countries.
Johnson & Johnson has an employee count of about 1,27,100. With an annual revenue of $70.074 billion, R & D expenditure of $9.046 billion and a basic EPS of $5.56, Johnson & Johnson is the Number 1 Pharmaceutical Company in the world.
The major segments of business of Johnson & Johnson are: Consumer, Pharmaceutical and Medical Devices, contributing to 13.2%, 37.3% and 27.2% of annual revenue, respectively.
The Consumer segment provides products under the categories like baby care, skin care, over-the-counter drugs, wound care and women’s health, with leading brands like Band-Aid, Benadryl, Johnson’s, Stayfree, Neutrogena and Clean & Clear on its portfolio. The Pharmaceuticals segment offers medicines under the verticals of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic. Medical Devices are offered for orthopedics, surgery, cardiovascular, diabetes care, surgery and vision care.
Johnson & Johnson was ranked 37th in the Fortune Global 500 Companies list, 2015 and was also ranked 11th in the World’s Most Admired Companies List. On May 18, 2016, Johnson & Johnson entered into collaboration with a 3D printing subsidiary of HP Inc, showing its commitment to offer innovative healthcare solutions at affordable rates.